Warner Chilcott Shareholders Equity:
-600.00M for Dec. 31, 2012Warner Chilcott Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -600.00M |
| Sept. 30, 2012 | -660.00M |
| June 30, 2012 | 220.00M |
| March 31, 2012 | 169.00M |
| Dec. 31, 2011 | 69.00M |
| Sept. 30, 2011 | 40.52M |
| June 30, 2011 | 27.50M |
| March 31, 2011 | -62.82M |
| Dec. 31, 2010 | -65.64M |
| Sept. 30, 2010 | -86.22M |
| June 30, 2010 | 1.980B |
| March 31, 2010 | 1.867B |
| Dec. 31, 2009 | 1.889B |
| Sept. 30, 2009 | 1.894B |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
WCRX Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Actavis | 3.605B |
| Mylan | 2.871B |
| Valeant Pharmaceuticals International | 3.587B |
WCRX Shareholders Equity Rankings
| Overall |
32nd percentile 5158 of 7593 |
| Sector |
4th percentile 619 of 650 in Healthcare |
| Industry |
4th percentile 62 of 65 in Drug Manufacturers - Specialty & Generic |
WCRX Shareholders Equity Range, Past 5 Years
| Minimum | -660.00M | Sep 2012 |
| Maximum | 1.980B | Jun 2010 |
| Average | 725.47M |